BlackRock Investment Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$3.24M Buy
110,712
+5,335
+5% +$146K ﹤0.01% 1872
2016
Q3
$2.86M Sell
105,377
-365
-0.3% -$8.26K ﹤0.01% 1884
2016
Q2
$1.97M Buy
105,742
+10,419
+11% +$217K ﹤0.01% 2112
2016
Q1
$2.58M Buy
95,323
+1,172
+1% +$33.6K ﹤0.01% 1810
2015
Q4
$2.84M Buy
94,151
+8,471
+10% +$272K ﹤0.01% 1825
2015
Q3
$2.71M Buy
85,680
+647
+0.8% +$23.6K ﹤0.01% 1838
2015
Q2
$3.31M Buy
85,033
+21,576
+34% +$744K ﹤0.01% 1826
2015
Q1
$2.25M Buy
63,457
+2,567
+4% +$82.6K ﹤0.01% 1932
2014
Q4
$1.92M Sell
60,890
-311
-0.5% -$8.6K ﹤0.01% 2069
2014
Q3
$1.37M Buy
61,201
+1,271
+2% +$25.5K ﹤0.01% 2284
2014
Q2
$1.31M Buy
+59,930
New +$1.14M ﹤0.01% 2398

Other funds holding PAHC

BlackRock Investment Management's PAHC Position: Q4 2016 in Review

BlackRock Investment Management increased its Phibro Animal Health (PAHC) stake by 5.1% in Q4 2016, buying an estimated $146K and bringing the position to 110,712 shares worth $3.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1872.

BlackRock Investment Management first reported a position in PAHC in Q2 2014 and has held it in 11 quarters since. The position peaked at $3.31M in Q2 2015. 143 funds tracked by Wall St. Rank hold PAHC as of Q4 2016.

  • BlackRock Investment Management held 110,712 shares of Phibro Animal Health worth $3.24M as of Q4 2016.
  • BlackRock Investment Management bought 5,335 Phibro Animal Health shares in Q4 2016, an estimated $146K.
  • Phibro Animal Health made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1872 holding.
  • BlackRock Investment Management first reported a position in Phibro Animal Health in Q2 2014 and has held it in 11 quarters since.
  • BlackRock Investment Management's Phibro Animal Health position peaked at $3.31M in Q2 2015.
  • 143 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.